UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000–2001

Clinical microbiology and infection, 2003-07, Vol.9 (7), p.590-599

2003

Volltextzugriff (PDF)

Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States

International journal of antimicrobial agents, 2002, Vol.19 (1), p.21-31

2002

Volltextzugriff (PDF)

Longitudinal Assessment of Antipneumococcal Susceptibility in the United States

Antimicrobial Agents and Chemotherapy, 2002-08, Vol.46 (8), p.2651-2655

2002

Volltextzugriff (PDF)

In Vitro Activities of Novel Nonfluorinated Quinolones PGE 9262932 and PGE 9509924 against Clinical Isolates of Staphylococcus aureus and Streptococcus pneumoniae with Defined Mutations in DNA Gyrase and Topoisomerase IV

Antimicrobial Agents and Chemotherapy, 2002-06, Vol.46 (6), p.1651-1657

2002

Volltextzugriff (PDF)

Effect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trial

The Lancet. Microbe, 2024-04, Vol.5 (4), p.e355-e365

2024

Volltextzugriff (PDF)

Factors Associated with Relative Rates of Antimicrobial Resistance among Streptococcus pneumoniae in the United States: Results from the TRUST Surveillance Program (1998–2002)

Clinical infectious diseases, 2003-04, Vol.36 (8), p.963-970

2003

Volltextzugriff (PDF)

Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999–2000

International journal of antimicrobial agents, 2002-08, Vol.20 (2), p.100-107

2002

Volltextzugriff (PDF)

Regional Trends in Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST Surveillance Program, 1999–2000

Clinical infectious diseases, 2002-03, Vol.34 (Supplement-1), p.S4-S16

2002

Volltextzugriff (PDF)

Recent advances in the preclinical evaluation of the topical antibacterial agent REP8839

Current opinion in chemical biology, 2008-08, Vol.12 (4), p.409-417

2008

Volltextzugriff (PDF)

Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000–2001

Journal of antimicrobial chemotherapy, 2003-03, Vol.51 (3), p.639-649

2003

Volltextzugriff (PDF)

Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal Analysis

Antimicrobial Agents and Chemotherapy, 2001-04, Vol.45 (4), p.1037-1042

2001

Volltextzugriff (PDF)

Optimal use of antibiotic resistance surveillance systems

Clinical microbiology and infection, 2004-06, Vol.10 (6), p.502-511

2004

Volltextzugriff (PDF)

Antibacterial Activity of REP8839, a New Antibiotic for Topical Use

Antimicrobial Agents and Chemotherapy, 2005-10, Vol.49 (10), p.4247-4252

2005

Volltextzugriff (PDF)

Mode of Action and Biochemical Characterization of REP8839, a Novel Inhibitor of Methionyl-tRNA Synthetase

Antimicrobial Agents and Chemotherapy, 2005-10, Vol.49 (10), p.4253-4262

2005

Volltextzugriff (PDF)

Baseline Study To Determine In Vitro Activities of Daptomycin against Gram-Positive Pathogens Isolated in the United States in 2000-2001

Antimicrobial Agents and Chemotherapy, 2003-05, Vol.47 (5), p.1689-1693

2003

Volltextzugriff (PDF)

Evaluation of Current Activities of Fluoroquinolones against Gram-Negative Bacilli Using Centralized In Vitro Testing and Electronic Surveillance

Antimicrobial Agents and Chemotherapy, 2001-01, Vol.45 (1), p.267-274

2001

Volltextzugriff (PDF)

Susceptibilities to Levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Clinical Isolates from Children: Results from 2000-2001 and 2001-2002 TRUST Studies in the United States

Antimicrobial Agents and Chemotherapy, 2003-06, Vol.47 (6), p.1790-1797

2003

Volltextzugriff (PDF)

In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe

Clinical microbiology and infection, 2002-04, Vol.8 (4), p.214-221

2002

Volltextzugriff (PDF)

Analysis of Ciprofloxacin Activity against Streptococcus pneumoniae after 10 Years of Use in the United States

Antimicrobial Agents and Chemotherapy, 2000-09, Vol.44 (9), p.2521-2524

2000

Volltextzugriff (PDF)

Antimicrobial Surveillance of Haemophilus influenzae in the United States during 2000-2001 Leads to Detection of Clonal Dissemination of a β-Lactamase-Negative and Ampicillin-Resistant Strain

Journal of Clinical Microbiology, 2002-03, Vol.40 (3), p.1063-1066

2002

Volltextzugriff (PDF)

Development of a Standardized Susceptibility Test for Campylobacter with Quality-Control Ranges for Ciprofloxacin, Doxycycline, Erythromycin, Gentamicin, and Meropenem

Microbial drug resistance (Larchmont, N.Y.), 2004-06, Vol.10 (2), p.124-132

2004

Volltextzugriff (PDF)

Uptake of a catecholic cephalosporin by the iron transport system of Escherichia coli

Journal of antimicrobial chemotherapy, 1991-09, Vol.28 (3), p.377-388

1991

Volltextzugriff (PDF)

Activities of Faropenem, an Oral β-Lactam, against Recent U.S. Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

Antimicrobial Agents and Chemotherapy, 2002-02, Vol.46 (2), p.550-555

2002

Volltextzugriff (PDF)

REVIEW: Optimal use of antibiotic resistance surveillance systems

Clinical microbiology and infection, 2004-06, Vol.10 (6), p.502-511

2004

Volltextzugriff (PDF)

Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains

Diagnostic microbiology and infectious disease, 2005-12, Vol.53 (4), p.311-317

2005

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000–2001

Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States

Longitudinal Assessment of Antipneumococcal Susceptibility in the United States

In Vitro Activities of Novel Nonfluorinated Quinolones PGE 9262932 and PGE 9509924 against Clinical Isolates of Staphylococcus aureus and Streptococcus pneumoniae with Defined Mutations in DNA Gyrase and Topoisomerase IV

Effect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trial

Factors Associated with Relative Rates of Antimicrobial Resistance among Streptococcus pneumoniae in the United States: Results from the TRUST Surveillance Program (1998–2002)

Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999–2000

Regional Trends in Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST Surveillance Program, 1999–2000

Recent advances in the preclinical evaluation of the topical antibacterial agent REP8839

Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000–2001

Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal Analysis

Optimal use of antibiotic resistance surveillance systems

Antibacterial Activity of REP8839, a New Antibiotic for Topical Use

Mode of Action and Biochemical Characterization of REP8839, a Novel Inhibitor of Methionyl-tRNA Synthetase

Baseline Study To Determine In Vitro Activities of Daptomycin against Gram-Positive Pathogens Isolated in the United States in 2000-2001

Evaluation of Current Activities of Fluoroquinolones against Gram-Negative Bacilli Using Centralized In Vitro Testing and Electronic Surveillance

Susceptibilities to Levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Clinical Isolates from Children: Results from 2000-2001 and 2001-2002 TRUST Studies in the United States

In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe

Analysis of Ciprofloxacin Activity against Streptococcus pneumoniae after 10 Years of Use in the United States

Antimicrobial Surveillance of Haemophilus influenzae in the United States during 2000-2001 Leads to Detection of Clonal Dissemination of a β-Lactamase-Negative and Ampicillin-Resistant Strain

Development of a Standardized Susceptibility Test for Campylobacter with Quality-Control Ranges for Ciprofloxacin, Doxycycline, Erythromycin, Gentamicin, and Meropenem

Uptake of a catecholic cephalosporin by the iron transport system of Escherichia coli

Activities of Faropenem, an Oral β-Lactam, against Recent U.S. Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

REVIEW: Optimal use of antibiotic resistance surveillance systems

Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains

Suchergebnisse filtern